{"id":"https://openalex.org/W4310162529","doi":"https://doi.org/10.1182/blood-2022-166939","title":"Clinical Outcomes in De Novo Versus Secondary NPM1-Mutated AML","display_name":"Clinical Outcomes in De Novo Versus Secondary NPM1-Mutated AML","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310162529","doi":"https://doi.org/10.1182/blood-2022-166939"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-166939","doi":"https://doi.org/10.1182/blood-2022-166939","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-166939","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042594281","display_name":"Elliot Charles Smith","orcid":"https://orcid.org/0009-0008-0911-1993","observed_orcids":["https://orcid.org/0009-0008-0911-1993"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Elliot C. Smith","raw_affiliation_strings":["1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","2Department of Medicine, University of Toronto, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]},{"raw_affiliation_string":"2Department of Medicine, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057593975","display_name":"Eshetu G. Atenafu","orcid":"https://orcid.org/0000-0002-4613-3680","observed_orcids":["https://orcid.org/0000-0002-4613-3680"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Eshetu G. Atenafu","raw_affiliation_strings":["3Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010559518","display_name":"Aniket Bankar","orcid":"https://orcid.org/0000-0002-0140-0538","observed_orcids":["https://orcid.org/0000-0002-0140-0538"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Aniket Bankar","raw_affiliation_strings":["1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059745705","display_name":"Steven M. Chan","orcid":"https://orcid.org/0000-0002-4354-0731","observed_orcids":["https://orcid.org/0000-0002-4354-0731"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Steven M. Chan","raw_affiliation_strings":["1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019264272","display_name":"Marta Beata Davidson","orcid":"https://orcid.org/0000-0001-6978-1368","observed_orcids":["https://orcid.org/0000-0001-6978-1368"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Marta B. Davidson","raw_affiliation_strings":["1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067214379","display_name":"Vikas K Gupta","orcid":"https://orcid.org/0000-0002-1419-8607","observed_orcids":["https://orcid.org/0000-0002-1419-8607"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Vikas Gupta","raw_affiliation_strings":["1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","2Department of Medicine, University of Toronto, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]},{"raw_affiliation_string":"2Department of Medicine, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026397928","display_name":"Mark David Minden","orcid":"https://orcid.org/0000-0002-9089-8816","observed_orcids":["https://orcid.org/0000-0002-9089-8816"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mark D. Minden","raw_affiliation_strings":["1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","2Department of Medicine, University of Toronto, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]},{"raw_affiliation_string":"2Department of Medicine, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043364502","display_name":"Guillaume Richard\u2010Carpentier","orcid":"https://orcid.org/0000-0001-6452-8814","observed_orcids":["https://orcid.org/0000-0001-6452-8814"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Guillaume Richard-Carpentier","raw_affiliation_strings":["1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045250493","display_name":"Aaron David Schimmer","orcid":"https://orcid.org/0000-0003-4023-3899","observed_orcids":["https://orcid.org/0000-0003-4023-3899"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Aaron D. Schimmer","raw_affiliation_strings":["2Department of Medicine, University of Toronto, Toronto, Canada","4Division of Medical Oncology and Hematology, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicine, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"4Division of Medical Oncology and Hematology, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002489867","display_name":"Andre C. Schuh","orcid":"https://orcid.org/0000-0003-2869-852X","observed_orcids":["https://orcid.org/0000-0003-2869-852X"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Andre C. Schuh","raw_affiliation_strings":["2Department of Medicine, University of Toronto, Toronto, Canada","4Division of Medical Oncology and Hematology, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicine, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"4Division of Medical Oncology and Hematology, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048157762","display_name":"Hassan Abdulmaoula Sibai","orcid":"https://orcid.org/0000-0001-9030-8583","observed_orcids":["https://orcid.org/0000-0001-9030-8583"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Hassan Sibai","raw_affiliation_strings":["2Department of Medicine, University of Toronto, Toronto, Canada","5Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicine, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"5Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055906478","display_name":"Karen W L Yee","orcid":"https://orcid.org/0000-0002-2572-9952","observed_orcids":["https://orcid.org/0000-0002-2572-9952"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Karen Yee","raw_affiliation_strings":["2Department of Medicine, University of Toronto, Toronto, Canada","5Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicine, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"5Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085305707","display_name":"Dawn C. Maze","orcid":"https://orcid.org/0000-0002-4598-9380","observed_orcids":["https://orcid.org/0000-0002-4598-9380"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Dawn Maze","raw_affiliation_strings":["1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","2Department of Medicine, University of Toronto, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]},{"raw_affiliation_string":"2Department of Medicine, University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.1823,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.54078843,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"8952","last_page":"8953"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/npm1-mutation","display_name":"NPM1 mutation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/secondary-acute-myeloid-leukemia","display_name":"secondary acute myeloid leukemia","score":0.9120000004768372},{"id":"https://openalex.org/keywords/de-novo-acute-myeloid-leukemia","display_name":"de novo acute myeloid leukemia","score":0.9539999961853027},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.8939999938011169},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.8870000243186951},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.7720000147819519},{"id":"https://openalex.org/keywords/therapy-related-myeloid-neoplasms","display_name":"therapy-related myeloid neoplasms","score":0.828000009059906},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8389999866485596},{"id":"https://openalex.org/keywords/leukemia-free-survival","display_name":"leukemia-free survival","score":0.9860000014305115},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C2483381","wikidata":"https://www.wikidata.org/wiki/Q18030194","display_name":"NPM1","level":5,"score":0.9126946926116943},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6466798782348633},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.624117910861969},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6234303712844849},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6115407943725586},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.45068541169166565},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.41824203729629517},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1933220624923706},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08279341459274292},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08268719911575317},{"id":"https://openalex.org/C53226629","wikidata":"https://www.wikidata.org/wiki/Q189967","display_name":"Karyotype","level":4,"score":0.06518155336380005},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-166939","doi":"https://doi.org/10.1182/blood-2022-166939","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-166939","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7799999713897705}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4401431808","https://openalex.org/W4281259838","https://openalex.org/W4389233771","https://openalex.org/W2980150194","https://openalex.org/W4200230548","https://openalex.org/W4310120370","https://openalex.org/W4295900064","https://openalex.org/W4390570422","https://openalex.org/W7202354708","https://openalex.org/W4405042963"],"abstract_inverted_index":{"Introduction":[0],"Nucleophosphomin-1":[1],"(NPM1)":[2],"mutated":[3],"AML":[4,57,89,119,150,186,204,231,325,404,442,450],"is":[5,30,64,77,559],"a":[6,49,60,83,156,272,276,437,555,561,569],"molecularly":[7],"defined":[8,152],"subtype":[9],"typically":[10],"associated":[11,66],"with":[12,67,113,144,155,388,452,479],"more":[13,391,413,462],"favourable":[14],"treatment":[15,69,332,443,592],"response":[16,70],"rates":[17,71],"and":[18,27,34,48,72,116,131,206,246,248,281,318,348,410,429,461,549],"prognosis.":[19,565],"Within":[20],"chronic":[21,159,278],"phase":[22,160],"myeloid":[23,62,161,279,296,310,557],"neoplasms,":[24],"including":[25,333,605],"MDS":[26,300],"MPN,":[28],"NPM1":[29,46,80,585,625],"observed":[31,476,544,615],"less":[32],"frequently,":[33],"previous":[35,513],"studies":[36,96,514,620],"have":[37,174,416,515,609],"suggested":[38],"an":[39,45,396,587],"association":[40],"between":[41,127,477,545],"the":[42,101,165,213,236,253,258,582,594,600,622,630],"presence":[43,379],"of":[44,52,104,167,178,203,215,275,291,380,403,563,584,624,632],"mutation":[47],"rapid":[50],"rate":[51,631],"progression":[53,229,355,573,613,634],"to":[54,173,185,228,230,288,324,354,356,363,393,415,447,572,574,611],"acute":[55],"leukemia.":[56],"evolving":[58],"from":[59,201,212,554],"prior":[61,184,227],"neoplasm":[63,297,311],"generally":[65],"unfavourable":[68],"survival":[73,102,140,208,237,240,500],"outcomes.":[74],"However,":[75],"it":[76],"unclear":[78],"if":[79],"mutations":[81,417],"remain":[82],"positive":[84],"prognostic":[85],"indicator":[86],"within":[87,520,529],"secondary":[88,117],"(sAML).":[90],"At":[91],"present,":[92],"there":[93,367,522],"are":[94,523,635],"limited":[95,524],"investigating":[97,621],"potential":[98],"differences":[99,249,538],"in":[100,190,235,265,372,418,440,444,485,539,576,591,602,616],"outcome":[103,137],"NPM1-mutated":[105,118,260,480,531,546],"sAML.":[106,148],"Methods":[107],"This":[108],"study":[109,567],"included":[110,189,234,299],"adults":[111],"diagnosed":[112,158],"de":[114,145,364,448,481,493,505,547],"novo":[115,146,365,449,482,494,506,548],"first":[120],"seen":[121],"at":[122,179,395,401],"Princess":[123],"Margaret":[124],"Cancer":[125],"Center":[126],"January":[128],"1,":[129],"2000,":[130],"April":[132],"21,":[133],"2021.":[134],"The":[135],"primary":[136],"was":[138,151,199,210,358,368,436,472],"overall":[139],"(OS),":[141],"comparing":[142],"patients":[143,261,270,285,329,454,463,478,578],"versus":[147,483],"Secondary":[149],"as":[153,193,586,597,599],"those":[154],"previously":[157],"malignancy":[162,558],"that":[163,552],"preceded":[164],"diagnosis":[166,187,274,405],"AML.":[168,532],"Patients":[169,218,387],"who":[170,219],"were":[171,188,232,242,250,286,390,411,543],"found":[172],"prolonged,":[175],"unexplained":[176],"cytopenias":[177],"least":[180],"6":[181],"months":[182,360],"duration":[183],"this":[191],"category":[192],"suspicious":[194,290],"for":[195,244,263],"preceding":[196,277,292,556,603],"MDS.":[197,293],"OS":[198,245,498,540],"calculated":[200,211],"date":[202,214],"diagnosis,":[205],"leukemia-free":[207],"(LFS)":[209],"achieving":[216],"CR1.":[217],"received":[220,330],"allogeneic":[221],"hematopoietic":[222],"stem":[223],"cell":[224],"transplant":[225],"(HSCT)":[226],"not":[233,560],"analysis.":[238],"Kaplan-Meier":[239],"curves":[241],"generated":[243],"LFS,":[247],"tested":[251],"using":[252],"log-rank":[254],"test.":[255],"Results":[256],"Of":[257],"575":[259],"eligible":[262],"inclusion":[264],"our":[266,534],"study,":[267,535],"40":[268],"(7%)":[269],"had":[271],"confirmed":[273,295],"neoplasm,":[280],"14":[282],"(2%)":[283],"additional":[284],"considered":[287],"be":[289,394],"Preceding":[294],"diagnoses":[298],"(n=18,":[301],"45%),":[302],"CMML":[303],"(n=14,":[304],"35%),":[305],"MPN":[306],"(n=4,":[307],"10%),":[308],"therapy-related":[309],"(n=2,":[312,350],"5%),":[313],"atypical":[314],"CML":[315],"(n=1,":[316,321,346],"3%),":[317],"MDS/MPN":[319,595],"unclassifiable":[320],"3%).":[322,470],"Prior":[323],"progression,":[326],"22":[327],"(55%)":[328],"disease-specific":[331],"azacytidine":[334],"(n=7,":[335],"18%),":[336],"erythropoiesis":[337],"stimulating":[338],"agents":[339],"(n=8,":[340],"20%),":[341],"hydroxyurea":[342],"(n=6,":[343],"15%),":[344],"ruxolitinib":[345],"3%)":[347],"HSCT":[349],"5%).":[351],"Median":[352],"time":[353,402,571],"sAML":[357,389,445,484,490,502,575,633],"3.2":[359],"(0.1-79.3).":[361],"Compared":[362],"AML,":[366,495,507],"no":[369,473,536],"significant":[370,438,474,537],"difference":[371,439,475],"sex":[373],"(p=0.39),":[374],"ELN":[375],"2017":[376],"risk":[377],"(p=0.10),":[378],"FLT3-ITD":[381],"(p=0.38),":[382],"or":[383,497,541],"karyotypic":[384],"abnormalities":[385],"(p=0.16).":[386],"likely":[392,414],"advanced":[397],"age":[398],"(\u226570":[399],"years)":[400],"(39%":[406],"vs":[407,421,426,432,459,469,491,503],"22%,":[408],"p=0.01),":[409,423],"also":[412],"RUNX1":[419],"(14%":[420],"3%,":[422],"CBL":[424],"(9%":[425],"2%,":[427],"p=0.04),":[428],"NRAS":[430],"(26%":[431],"11%,":[433],"p=0.02).":[434],"There":[435,471],"first-line":[441],"compared":[446],"(p<0.0001),":[451],"fewer":[453],"receiving":[455,464],"induction":[456],"therapy":[457,467],"(67%":[458],"84%)":[460],"hypomethylating":[465],"agent-based":[466],"(22%":[468],"LFS":[486,488,542],"(2-year":[487,499],"48%":[489],"52%":[492],"p=0.74)":[496],"46%":[501],"56%":[504],"p=0.14)":[508],"(figure":[509],"1).":[510],"Conclusion":[511],"While":[512],"demonstrated":[516,568],"poor":[517,564],"clinical":[518],"outcomes":[519,527],"sAML,":[521,550],"investigations":[525],"studying":[526],"specifically":[528],"secondary,":[530],"In":[533],"suggesting":[551],"evolution":[553],"predictor":[562],"Our":[566],"short":[570],"most":[577],"which":[579],"further":[580],"supports":[581],"consideration":[583],"AML-defining":[588],"mutation.":[589],"Variations":[590],"during":[593],"stage,":[596],"well":[598],"heterogeneity":[601],"diagnoses,":[604],"polycythemia":[606],"vera,":[607],"may":[608],"contributed":[610],"longer":[612],"latency":[614],"some":[617],"cases.":[618],"Future":[619],"impact":[623],"variant":[626],"allele":[627],"frequency":[628],"on":[629],"planned.":[636],"Figure":[637],"1View":[638,641],"largeDownload":[639,642],"PPTFigure":[640],"PPT":[643],"Close":[644],"modal":[645]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2022-11-30T00:00:00"}